215 related articles for article (PubMed ID: 30240449)
1. Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database.
Hsu JC; Wu HC; Feng WC; Chou CH; Lai EC; Lu CY
PLoS One; 2018; 13(9):e0204206. PubMed ID: 30240449
[TBL] [Abstract][Full Text] [Related]
2. Analysis of economic burden and its associated factors of twenty-three rare diseases in Shanghai.
Cai X; Yang H; Genchev GZ; Lu H; Yu G
Orphanet J Rare Dis; 2019 Oct; 14(1):233. PubMed ID: 31640704
[TBL] [Abstract][Full Text] [Related]
3. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
4. Geographic Variations and Time Trends in Cancer Treatments in Taiwan.
Hsu JC; Chang SM; Lu CY
BMC Public Health; 2017 Aug; 18(1):89. PubMed ID: 28768504
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study.
Hsu JC; Lu CY
BMJ Open; 2016 Jun; 6(6):e011322. PubMed ID: 27266775
[TBL] [Abstract][Full Text] [Related]
6. Outpatient drug expenditures and prescription policies for diseases with high cost to the National Health Insurance system in Taiwan.
Lang HC; Lai MS; Chen GT
J Formos Med Assoc; 2004 Apr; 103(4):280-5. PubMed ID: 15175823
[TBL] [Abstract][Full Text] [Related]
7. Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013.
Wang CY; Fu SH; Yang RS; Shen LJ; Wu FL; Hsiao FY
Arch Osteoporos; 2017 Oct; 12(1):92. PubMed ID: 29067572
[TBL] [Abstract][Full Text] [Related]
8. Estimating medical costs of gastroenterological diseases.
Chou LF
World J Gastroenterol; 2004 Jan; 10(2):273-8. PubMed ID: 14716838
[TBL] [Abstract][Full Text] [Related]
9. Increasing age- and gender-specific burden and complexity of multimorbidity in Taiwan, 2003-2013: a cross-sectional study based on nationwide claims data.
Hu RH; Hsiao FY; Chen LJ; Huang PT; Hsu WW
BMJ Open; 2019 Jun; 9(6):e028333. PubMed ID: 31182451
[TBL] [Abstract][Full Text] [Related]
10. Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study.
Hsu JC; Lu CY; Wagner AK; Chan KA; Lai MS; Ross-Degnan D
Health Policy; 2014 Jun; 116(2-3):196-205. PubMed ID: 24314624
[TBL] [Abstract][Full Text] [Related]
11. Variations in the persistence of health expenditures and the implications for the design of capitation payments in Taiwan.
Ku LJ; Chiou MJ; Liu LF
J Health Serv Res Policy; 2015 Jul; 20(3):146-53. PubMed ID: 25829410
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan.
Wu DB; Roberts CS; Huang YC; Chien L; Fang CH; Chang CJ
J Med Econ; 2014 May; 17(5):312-9. PubMed ID: 24575941
[TBL] [Abstract][Full Text] [Related]
13. The cost of schizophrenia treatment in Taiwan.
Lang HC; Su TP
Psychiatr Serv; 2004 Aug; 55(8):928-30. PubMed ID: 15292543
[TBL] [Abstract][Full Text] [Related]
14. Comparison of alternative risk adjustment measures for predictive modeling: high risk patient case finding using Taiwan's National Health Insurance claims.
Chang HY; Lee WC; Weiner JP
BMC Health Serv Res; 2010 Dec; 10():343. PubMed ID: 21172009
[TBL] [Abstract][Full Text] [Related]
15. National trends in incidence, mortality, hospitalizations, and expenditures for pemphigus in Taiwan.
Chiu HY; Chang CJ; Lin YJ; Tsai TF
J Dermatol Sci; 2020 Sep; 99(3):203-208. PubMed ID: 32859457
[TBL] [Abstract][Full Text] [Related]
16. The evolution of Taiwan's National Health Insurance drug reimbursement scheme.
Hsu JC; Lu CY
Daru; 2015 Feb; 23(1):15. PubMed ID: 25889754
[TBL] [Abstract][Full Text] [Related]
17. Socio-economic burden of rare diseases: A systematic review of cost of illness evidence.
Angelis A; Tordrup D; Kanavos P
Health Policy; 2015 Jul; 119(7):964-79. PubMed ID: 25661982
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program.
Ho YC; Lee PL; Wang YC; Chen SC; Chen KT
Hum Vaccin Immunother; 2015; 11(5):1081-7. PubMed ID: 25874476
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
[TBL] [Abstract][Full Text] [Related]
20. Assessing a population's need for scintigraphy: use under universal health insurance in Taiwan.
Chan WP; Liao CH; Hsu CH; Yang CM
Nucl Med Commun; 2010 May; 31(5):375-9. PubMed ID: 20072073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
